Phase I Study of Ascending Doses of MMV390048 in Healthy Adult Volunteers

NCT02230579 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

48

Enrollment

OTHER

Sponsor class

Conditions

Malaria

Interventions

DRUG: MMV390048 5mg
DRUG: MMV390048 20mg
DRUG: MMV390048 40mg
DRUG: MMV390048 80mg
DRUG: MMV390048 120mg
DRUG: Placebo to match MMV390048

Sponsor

Medicines for Malaria Venture

Collaborators

[object Object]